Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer

European Journal of Surgical Oncology

Volumn 30, Issue 6, 2004, Pages 681-685

  Hamy, A ^a,d   Mirallie E ^b   Bennouna, J ^c   Resche, I ^c   Drefty, C ^a   Johnstone, M ^a   Visset, J ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c CENTRE RENÉ GAUDUCHEAU   (France)

^d CHU de Nantes   (France)

Author keywords

Differentiated thyroid cancer; Recurrence; Surgery; Thyroglobulin

Indexed keywords

IODINE 131; RADIOACTIVE IODINE; THYROGLOBULIN;

ADOLESCENT; ADULT; CANCER GROWTH; CANCER LOCALIZATION; CANCER RECURRENCE; CERVICAL LYMPH NODE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID SCINTISCANNING; THYROIDECTOMY; TREATMENT PLANNING;

EID: 4043151992     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.03.018     Document Type: Article

References (33)

1. Visset J. Chigot J.P. Arnette Initiatives Santé (ed.) Le traitement du cancer du corps thyröde 1998 Monographie de l'Association Française de Chirurgie Paris st
2. Asakawa H. Kobayashi T. Komoike Y. et al. Prognostic factors in patients with recurrent differentiated thyroid carcinoma J Surg Oncol 64 1997 202-206
3. Coburn M. Teates D. Wanebo H. Recurrent thyroid cancer. Role of surgery versus radio-active iodine Ann Surg 219 1994 587-593
4. Rossi R.L. Cady B. Silverman M. Wool M. Horner T. Current results of conservative surgery for differentiated thyroid carcinoma World J Surg 10 1986 612-622
5. Sanders L.E. Cady B. Differentiated thyroid cancer. Reexamination of risk groups and outcome of treatment Arch Surg 133 1998 419-425
6. Hoie J. Stenwig A.E. Kullmann G. Lindegoard M. Distant metastases in papillary thyroid cancer. A review of 91 patients Cancer 61 1988 1-6
7. McCohaney W. Hay J. Woolner L. Van Heerden J. Taylor W. Papillary thyroid cancer treated at the Mayo Clinic 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome Mayo Clin Proc 61 1986 978-996
8. McHenry C. Rosen I. Walfish P. Prospective management of nodal metastases in differentiated thyroid cancer Am J Surg 4 1991 353-356
9. Massin J. Savoie J. Garnier H. Guiraudon G. Leger F. Bacourt F. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for primary tumor treatment Cancer 53 1984 982-992
10. Schindler A.M. Van Melle G. Evequoz B. Scazziza B. Prognostic factors in papillary carcinoma of the thyroid Cancer 68 1991 324-330
11. Vassilopoulou R. Schultz P. Haynie T. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radio-active iodine therapy Cancer 78 1996 493-501
12. Schlumberger M. Medical progress: papillary and follicular thyroid carcinoma N Engl J Med 338 1998 297-306
13. Hamby L. McGrath P. Schwartz R. Sloan D. Simpson W. Kenady D. Management of local recurrence in well-differentiated thyroid carcinoma J Surg Res 52 1992 113-117
14. Iida Y. Hidaka A. Hatabu H. Kasagi H. Konishi J. Follow-up study of post-operative patients with thyroid cancer thallium 201 scintigraphy and serum thyroglobulin measure J Nucl Med 32 1991 2098-2100
15. Lerch H. Schober O. Kuwert T. Saur H.B. Survival of differentiated thyroid carcinoma studied in 500 patients J Clin Oncol 15 1997 2067-2075
16. Wartofsky L. Sherman S. Gopal J. Schlumberger M. Hay I. The use of radio-active iodine in patients with papillary and follicular thyroid cancer J Clin Endocrinol Metab 83 1998 4195-4203
17. Fatourechi V. Hay I. Mullan B. et al. Are post-therapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer? Thyroid 10 2000 573-577
18. Baudin E. Cailleux A.F. Travagli J.P. Parmentier C. Schlumberger M. Rechutes ganglionnaires des cancers thyrödiens différenciés Rev Franç Endocrinol Clin 40 1999 529-532
19. 131I whole body scans in thyroid cancer Br J Radiol 73 2000 627-635
20. Muller-Gartner M. Schneider C. Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer Cancer 61 1988 976-981
21. Baudin E. Schlumberger M. Lumbroso J. Travagli J.P. Caillou B. Parmentier C. Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan J Clin Endocrinol Metab 81 1996 2541-2544
22. Muros M. Liamas-Elvira J. Ramirez-Navarro A. et al. Utility of fluorine-18-fluorodeoxyglucose position emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels Am J Surg 179 2000 457-461
23. 131I scan J Nucl Med 42 2001 77-78
24. (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy J Nucl Med 42 2001 1464-1469
25. 18F]fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma Ann Surg 234 2001 804-811
26. 131I-negative papillary thyroid carcinoma J Nucl Med 41 2000 1010-1015
27. Westbury C. Vini L. Fisher C. Harmer C. Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin Thyroid 10 2000 171-176
28. Schlumberger M. Baudin E. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma Eur J Endocrinol 138 1998 249-252
29. Clark O.H. Hoelting T. Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin level and negative radioiodine scans Thyroid 4 1994 501-505
30. Pachucki J. Burmeister L. Evaluation and treatment of persistent thyroglobulinemia in patients with well differentiated thyroid cancer Eur J Endocrinol 137 1997 254-261
31. Pacini F. Cetani F. Miccoli P. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine World J Surg 18 1994 600-604
32. Pineda J.D. Lee T. Ain K. Reynolds J.G. Robbins J. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan J Clin Endocrinol Metab 80 1995 1488-1492
33. 131I activities versus untreated patients J Clin Endocrinol Metab 86 2001 4092-4097